COVID-19 Seroprevalence in Romania: Insights from a Nationwide Antibody Study

罗马尼亚新冠病毒血清阳性率:一项全国性抗体研究的启示

阅读:1

Abstract

BACKGROUND: Frequency indicators are used by epidemiologists to facilitate public health professionals in estimating the impact of diseases. As of April 2022, Romania had reported 2.8 million confirmed COVID-19 cases to the World Health Organization, equating to a prevalence rate of 13.94%. A more accurate method for assessing the cumulative number of cases is the use of seroprevalence studies. This study retrospectively evaluates infection trends in Romania to enhance understanding of the virus's spread and may support future comparative analyses of public health responses and community-level immunity. METHODS: We analyzed 51,533 qualitative test results for high-affinity IgG antibodies targeting the SARS-CoV-2 nucleocapsid protein. RESULTS: The largest proportion of tested individuals (59.4%) was aged 18-49 years. Among all serological tests, 18,980 were positive, corresponding to an adjusted seroprevalence rate of 40%. CONCLUSIONS: During the second year of the pandemic, seropositivity rates were highest among young adults, particularly in the western regions, and lowest among children and adolescents. These findings point out variations in exposure across age groups and geographic areas.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。